What is Prestige Consumer Healthcare Inc Quarterly Revenue?

Prestige Consumer Healthcare Inc Quarterly Revenue Prestige Consumer Healthcare Inc Jun-2026 Quarterly Revenue is $266 Million which is growth of 6.5% YoY.

What is Prestige Consumer Healthcare Inc Quarterly Net Profit?

Prestige Consumer Healthcare Inc Quarterly Net Profit Prestige Consumer Healthcare Inc Jun-2026 Quarterly Net Profit is $29 Million which is growth of -38.5% YoY.

What is Prestige Consumer Healthcare Inc Annual Revenue?

Prestige Consumer Healthcare Inc Annual Revenue Prestige Consumer Healthcare Inc Mar-2026 Annual Revenue is $1,089 Million which is growth of -4.3% YoY.

What is Prestige Consumer Healthcare Inc Annual Net Profit?

Prestige Consumer Healthcare Inc Annual Net Profit Prestige Consumer Healthcare Inc Mar-2026 Annual Net Profit is $190 Million which is growth of -11.3% YoY.

What is Prestige Consumer Healthcare Inc Total Shareholders Fund?

Prestige Consumer Healthcare Inc Total Shareholders Fund Prestige Consumer Healthcare Inc Mar-2026 Total Shareholders Fund is $1,888 Million which is growth of 2.9% YoY.

What is Prestige Consumer Healthcare Inc Total Assets?

Prestige Consumer Healthcare Inc Total Assets Prestige Consumer Healthcare Inc Mar-2026 Total Assets is $3,494 Million which is growth of 2.7% YoY.

What is Prestige Consumer Healthcare Inc Book Value Per Share?

Prestige Consumer Healthcare Inc Book Value Per Share Prestige Consumer Healthcare Inc Book Value Per Share is $40 which is growth of 7.3% YoY.

What is Prestige Consumer Healthcare Inc ROE?

Prestige Consumer Healthcare Inc ROE Prestige Consumer Healthcare Inc ROE is 10% which is growth of 2.1% YoY.

What is Prestige Consumer Healthcare Inc Cash From Operating Activity?

Prestige Consumer Healthcare Inc Cash From Operating Activity Prestige Consumer Healthcare Inc Mar-2026 Cash From Operating Activity is $258 Million which is growth of 2.4% YoY.

What is Prestige Consumer Healthcare Inc Net Cash Flow?

Prestige Consumer Healthcare Inc Net Cash Flow Prestige Consumer Healthcare Inc Mar-2026 Net Cash Flow is $-35 Million which is growth of -167.9% YoY.

Prestige Consumer Healthcare Inc

XNYS: PBH

Falling Comet

Download real time

0.34(0.75%)

35.84% Fall from 52W High

604.4K

XNYS Volume

XNYS 05 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Prestige Consumer Healthcare Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Prestige Consumer Healthcare Inc share price target, revenues, EPS, net income and more

Prestige Consumer Healthcare Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Prestige Consumer Healthcare Inc Jun-2026 Quarterly Revenue is $266 Million which is growth of 6.5% YoY.
NEGATIVE
Quarterly Net Profit Prestige Consumer Healthcare Inc Jun-2026 Quarterly Net Profit is $29 Million which is growth of -38.5% YoY.

Prestige Consumer Healthcare Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
SR_Q Operating Rev.	265.7	281.6	283.4	274.1	249.5	296.5	290.3	283.8	267.1	277	282.7	286.3	279.3
CostOfRevenue_Q Cost Of Rev.	129.5	135.3	126.1	122.5	109.2	126.5	129.3	126.4	121.1	125.2	124.8	126.3	124.6
GrossProfit_Q Gross Profit	136.2	146.3	157.4	151.6	140.3	170	161.1	157.4	146	151.8	157.9	160	154.7
OEXPNS_Q Operating Exp. ⌄	83.7	70.8	74.9	71.9	68.6	69.1	69.1	73	74	69.7	71.1	71.8	69.5
AdminAndSellingExpenses_Q Admin Plus Selling Exp.	78	65.4	69.7	66.7	63.4	64.1	64.1	67.5	68.3	64	65.5	66.1	63.9
ResearchAndDevlopmentExpenses_Q RnD Exp.	-	-	-	-	-	-	-	-	-	-	-	-	-
OP_Q Operating Profit	52.5	75.5	82.5	79.7	71.8	100.9	92	84.3	72.1	82.2	86.8	88.3	85.2
NetNonOperIntIncExp_Q Net Non Operations Interest Incuding Expenses ⌄	-14	-11.4	-10.7	-10	-10.2	-10.8	-11.5	-12.3	-13.1	-15.3	-16.6	-17.6	-17.7
Others_Q Other Interest Earned	-	-	-	-	-	-	-	-	-	-	-	-	-
IntExpNonOperating_Q Interest Exp. Non Operating	14	11.4	10.7	10	10.2	10.8	11.5	12.3	13.1	15.3	16.6	17.6	17.7
PBT_Q Profit Before Tax	38.5	64.8	61.8	69.1	61.8	74	80.2	71.7	58.4	67.3	69.6	70.4	68.7
TAX_Q Tax	9.4	10.8	15.1	26.9	14.3	23.8	19.1	17.3	9.3	17.9	16.5	16.9	15.4
NICommonStockholders_Q Net Income Common Stockholders ⌄	29.2	53.9	46.7	42.2	47.5	50.1	61	54.4	49.1	49.5	53.1	53.6	53.3
NP_Q Net Profit	29.2	53.9	46.7	42.2	47.5	50.1	61	54.4	49.1	49.5	53.1	53.6	53.3
NIIncludingNoncontrollingInterests_Q Net Income Including Non controlling Interests	29.2	53.9	46.7	42.2	47.5	50.1	61	54.4	49.1	49.5	53.1	53.6	53.3
DilutedNIAvailtoComStockholders_Q Diluted NI Avail to Com Stockholders Ann.	29.2	53.9	46.7	42.2	47.5	50.1	61	54.4	49.1	49.5	53.1	53.6	53.3
EPS_Q Basic EPS	0.6	1.1	1	0.9	1	1	1.2	1.1	1	1	1.1	1.1	1.1
AfterDilutedEPS_Q Diluted EPS After ExtraOrdinary	0.6	1.1	1	0.9	1	1	1.2	1.1	1	1	1.1	1.1	1.1
SHARE_Q Number Of Shares End	47.5	47.5	47.9	49	49.5	49.7	49.6	49.7	49.9	49.8	49.7	49.7	49.8
NIContinuingDiscontinuedOper_Q Net Income Continuing Discontinued Operations	29.2	53.9	46.7	42.2	47.5	50.1	61	54.4	49.1	49.5	53.1	53.6	53.3
NormalizedIncome_Q Normalized Income	29.2	53.9	46.7	42.2	47.5	50.1	61	54.4	49.1	49.5	53.1	53.6	53.3
InterestIncome_Q Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-
INT_Q Interest	13.9	11.4	10.7	10	10.2	10.8	11.5	12.3	13.1	15.3	16.6	17.6	17.7
NetInterestIncome_Q Net Interest Income	-14	-11.4	-10.7	-10	-10.2	-10.8	-11.5	-12.3	-13.1	-15.3	-16.6	-17.6	-17.7
EBIT_Q EBIT	52.5	76.2	72.5	79.2	72	84.7	91.6	83.9	71.6	82.6	86.2	88	86.4
EBITDA_Q EBITDA	61.2	84.6	80.1	86.8	79.7	92	98.5	91.9	79.7	90.4	93.8	95.7	94
ReconciledCostOfRevenue_Q Reconciled Cost Of Rev.	126.5	132.4	123.6	120	106.7	124.3	127.4	124	118.7	123	122.8	124.3	122.7
ReconciledDepreciation_Q Reconciled Depr.	8.8	8.4	7.6	7.7	7.7	7.3	6.9	7.9	8.1	7.8	7.7	7.6	7.5
ProfitLossFromContinuingOperations_Q Profit From Continuing Operations	29.2	53.9	46.7	42.2	47.5	50.1	61	54.4	49.1	49.5	53.1	53.6	53.3
NormalizedEBITDA_Q Normalized EBITDA	61.2	84.6	80.1	86.8	79.7	92	98.5	91.9	79.7	90.4	93.8	95.7	94

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Prestige Consumer Healthcare Inc competitor comparison and performance snapshot within industry

Prestige Consumer Healthcare Inc annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Annual Revenue Prestige Consumer Healthcare Inc Mar-2026 Annual Revenue is $1,089 Million which is growth of -4.3% YoY.
NEGATIVE
Annual Net Profit Prestige Consumer Healthcare Inc Mar-2026 Annual Net Profit is $190 Million which is growth of -11.3% YoY.

Prestige Consumer Healthcare Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	-1.2%	2.9%		1,088.7	1,137.8	1,125.4	1,127.7	1,086.8	943.4	963	975.8	1,041.2	882.1	806.3
TotalOperatingRevenues_A Operating Rev. Ann.	-1.3%	2.8%	1,104.9	1,084.7	1,136.6	1,125.1	1,127.6	1,086.8	943.3	962.9	975.7	1,040.8	881.1	803.1
CostOfRevenue_A Cost Of Rev. Ann.	-0.6%	4.5%	513.5	493.1	503.3	500.9	502.4	466.2	395.9	410.8	420.2	464.7	381.8	339
GrossProfit_A Gross Profit Ann.	-1.6%	1.7%	591.4	595.6	634.5	624.5	625.3	620.7	547.5	552.2	555.6	576.5	500.3	467.2
OEXPNS_A Operating Exp. Ann.	1%	2.7%	301.3	286.2	285.2	282	277.5	290.7	250.1	261.1	259.9	360.6	242.9	206.9
OP_A Operating Profit Ann.	-3.8%	0.8%	290.2	309.4	349.2	342.4	347.8	329.9	297.4	291.2	295.7	215.9	257.4	260.3
NetNonOperIntIncExp_A Net Non Operations Interest Incuding Expenses Ann, ⌄	-	-	-46.1	-42.3	-47.6	-67.2	-69.2	-64.3	-82.3	-96.2	-105.1	-105.9	-93.3	-85.2
Others_A Other Interest Earned Ann.	-	-		-	-	-	-	-	-	0.3	0.2	0.4	0.2	0.2
IntExpNonOperating_A Interest Exp. Non Operating Ann.	-15.1%	-12.5%	46.1	42.3	47.6	67.2	69.2	64.3	82.3	96.6	105.3	106.3	93.6	85.3
OtherExpenses_A Other Exp. Ann.	-	-		-9.6	-17.4	0.8	-372.6	-3.2	-11	-3.8	-228.7	-2.9	-53.2	-18
PBT_A PBT Ann.	-	4.8%	234.3	257.5	284.2	276	-93.9	262.5	204.1	191.2	-38.1	107.1	110.9	157.2
TAX_A Tax Ann.	-	11.3%	62.2	67.2	69.6	66.7	-11.6	57.1	39.4	48.9	-2.3	-232.5	41.5	57.3
NICommonStockholders_A Net Income Common Stockholders Ann. ⌄	-	2.9%	172	190.3	214.6	209.3	-82.3	205.4	164.7	142.3	-35.8	339.6	69.4	99.9
NP_A Net Profit Ann.	-	2.9%	172	190.3	214.6	209.3	-82.3	205.4	164.7	142.3	-35.8	339.6	69.4	99.9
NIIncludingNoncontrollingInterests_A Net Income Including Non controlling Interests Ann.	-	2.9%	172	190.3	214.6	209.3	-82.3	205.4	164.7	142.3	-35.8	339.6	69.4	99.9
DilutedNIAvailtoComStockholders_A Diluted NI Avail to Com Stockholders Ann.	-	2.9%	172	190.3	214.6	209.3	-82.3	205.4	164.7	142.3	-35.8	339.6	69.4	99.9
EPS_A EPS Ann.	-	3.4%		3.9	4.3	4.2	-1.7	4.1	3.3	2.8	-0.7	6.4	1.3	1.9
DilutedEPS_A Diluted EPS Ann.	-	3.4%		3.9	4.3	4.2	-1.7	4	3.3	2.8	-0.7	6.3	1.3	1.9
SHARE_Q Number Of Shares End	-1.6%	-1%		47.5	49.7	49.8	49.8	50.4	50	50.4	51.9	53.1	53	52.8
TotalExpenses_A Total Exp. Ann.	0%	3.8%		779.3	788.5	782.9	779.9	756.9	646	671.9	680.1	825.3	624.6	545.9
NIContinuingDiscontinuedOper_A Net Income Continuing Discontinued Operations Ann.	-	2.9%	172	190.3	214.6	209.3	-82.3	205.4	164.7	142.3	-35.8	339.6	69.4	99.9
NormalizedIncome_A Normalized Income Ann.	-7.7%	1.7%	172	190.3	224	209.3	242	207	174.6	143.9	178.9	341.7	102.7	111.3
InterestIncome_A Interest Income Ann.	-	-		-	-	-	-	-	-	0.3	0.2	0.4	0.2	0.2
INT_A Interest Ann.	-15.1%	-12.5%	46.1	42.3	47.6	67.2	69.2	64.3	82.3	96.6	105.3	106.3	93.6	85.3
EBITDA_A EBITDA Ann.	247.4%	0.9%	312.7	331.1	362	373.9	7.9	358.8	316.6	316.7	99	246.8	230.2	266.2
ReconciledCostOfRevenue_A Reconciled Cost Of Rev. Ann.	-0.8%	4.4%	502.5	482.8	494.4	492.8	494.9	458.9	389.7	406.6	415.5	459.7	381.3	339
ReconciledDepreciation_A Reconciled Depr. Ann.	-1.3%	0.7%	32.4	31.3	30.2	30.7	32.6	32.1	30.2	29	31.8	33.4	25.8	23.7
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	-	2.9%	172	190.3	214.6	209.3	-82.3	205.4	164.7	142.3	-35.8	339.6	69.4	99.9
NormalizedEBITDA_A Normalized EBITDA Ann.	-4.3%	0.1%	312.7	331.1	374.5	373.9	378.1	361	328.9	318.9	327.2	249.7	283.4	284.2

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

-4.3%

2Y CAGR

-1.6%

3Y CAGR

-1.2%

5Y CAGR

2.9%

7Y CAGR

1.6%

10Y CAGR

Total Revenue Annual is falling faster than historical averages.

Net Profit Ann.

1Y CHG

-11.3%

2Y CAGR

-4.6%

5Y CAGR

2.9%

10Y CAGR

6.7%

Net Profit Annual is falling faster than historical averages.

Operating Exp. Ann.

1Y CHG

0.4%

2Y CAGR

0.7%

3Y CAGR

5Y CAGR

2.7%

7Y CAGR

1.4%

10Y CAGR

3.3%

Operating Expenses Annual Cr growth is lower than historical averages.

Prestige Consumer Healthcare Inc balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Prestige Consumer Healthcare Inc Mar-2026 Total Shareholders Fund is $1,888 Million which is growth of 2.9% YoY.
POSITIVE
Total Assets Prestige Consumer Healthcare Inc Mar-2026 Total Assets is $3,494 Million which is growth of 2.7% YoY.

Prestige Consumer Healthcare Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TA_A Total Assets Ann. ⌄	1.4%	0.4%	3,494.3	3,402.2	3,318.4	3,353.7	3,670.7	3,429.3	3,513.9	3,441	3,760.6	3,911.4	2,948.8
CA_A Total Current Assets Ann.	3.3%	9.8%	431.5	448.3	375	391.7	293.3	269.8	365.7	300.9	303.5	334.4	249
CashEquivalentsShortTermInvestments_A Cash Equivalents and Short Term Investments Ann.	3%	14.6%	63.9	97.9	46.5	58.5	27.2	32.3	94.8	27.5	32.6	41.9	27.2
Receivables_A Change In Account Receivables Ann.	4.7%	10.8%	191.9	194.3	176.8	167	139.3	114.7	150.5	148.8	140.9	136.7	95.3
Inventories_A Inventories Ann.	-0.6%	6.7%	159.1	147.7	138.7	162.1	120.3	115	116	119.9	118.6	115.6	91.3
OtherCurrentAssets_A Other Current Assets Ann.	59.4%	16%	16.6	8.4	13.1	4.1	6.4	7.9	4.4	4.7	11.5	40.2	25.2
TotalNonCurrentAssets_A Total Non Current Assets Ann.	1.1%	-0.6%	3,062.8	2,953.9	2,943.4	2,962	3,377.4	3,159.4	3,148.3	3,140.1	3,457.1	3,576.9	2,699.8
NetPPE_A Net PPE Ann.	24.2%	10.8%	171.3	127.8	89.3	89.5	98.5	102.8	90.7	51.2	52.6	50.6	15.5
InvestmentsAndAdvances_A Investments & Advances Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
OtherNonCurrentAssets_A Other Non Current Assets Ann.	53.7%	30.3%	10.9	3.3	5.7	3	3.3	2.9	3	3.1	3.6	7.5	1.3
TotalLiabilitiesNetMinorityInterest_A Total Liabilities Net Minority Interest Ann. ⌄	-5.5%	-4.9%	1,606.8	1,567.3	1,663.3	1,906.6	2,093.1	2,071	2,342.9	2,345.2	2,582	3,088.8	2,204.5
CL_A Total Current Liabilities Ann.	-9%	-0.2%	120.9	106.6	117.1	160.7	143.4	122.1	149.9	127	123.2	162	106.7
PayablesAndAccruedExpenses_A Payables & Accrued Exp.s Ann.	-11%	-0.7%	96.3	83.9	98.7	136.7	114.7	99.6	129.7	116	112.6	146	96.3
CurrentDebtCapLeaseObligation_A Current Debt Cap Lease Obligation Ann.	8.7%	8.2%	12.6	8.5	6.2	9.8	9.1	8.5	6.8	-	-	-	-
CurrentDeferredLiabilities_Q Current Deferred Liabilities	-	-	-	-	-	-	-	-	-	-	-	0.5	0.8
OtherCurrentLiabilities_A Other Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann.	-5.2%	-5.3%	1,485.9	1,460.7	1,546.3	1,745.9	1,949.7	1,948.8	2,193.1	2,218.2	2,458.8	2,926.8	2,097.8
LongTermDebtAndCapitalLeaseObligation_Q LT Debt & Capital Lease Obligation	-8.7%	-7.3%	1,032.9	1,035.7	1,133.5	1,357.3	1,497.3	1,506.2	1,759.8	1,798.6	1,993	2,193.7	1,625.3
TradeandOtherPayablesNonCurrent_A Trade & Other Payables Non Current Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalDeferredCreditsAndOtherNonCurrentLiabilities_A Total Deferred Credits & Other Non Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	9.3%	6.8%	1,887.5	1,834.9	1,655.1	1,447.1	1,577.6	1,358.3	1,171	1,095.8	1,178.6	822.6	744.3
EQCAP_A Equity Share Capital Ann.	9.3%	6.8%	1,887.5	1,834.9	1,655.1	1,447.1	1,577.6	1,358.3	1,171	1,095.8	1,178.6	822.6	744.3
CapitalStock_A Capital Stock Ann.	0%	3.7%	0.6	0.6	0.6	0.6	0.5	0.5	0.5	0.5	0.5	0.5	0.5
RetainedEarnings_A Retained Earnings Ann.	15.5%	11.6%	1,746.1	1,555.8	1,341.2	1,131.9	1,214.2	1,008.8	844.1	701.8	736.3	396.7	327.3
GainsLossesNotAffectingRetainedEarnings_A Gains Losses Not Affecting Retained Earnings Ann.	-	-	-28.4	-37.7	-34.5	-31.6	-19	-19.8	-44.2	-25.8	-19.3	-26.4	-23.5
TotalCapitalization_A Total Capitalization Ann.	1%	0.3%	2,881.5	2,827.3	2,780.9	2,792.9	3,054.3	2,838	2,901.3	2,894.4	3,171.6	3,016.3	2,369.6
TangibleAssets_A Tangible Assets Ann.	-	-	-993.2	-987.9	-1,193.2	-1,422.4	-1,698	-1,695.5	-1,883.6	-1,990	-2,222.4	-2,696.3	-1,938.6
WC_A Working Capital Ann.	10.4%	16%	310.6	341.7	258	231	149.8	147.7	215.8	174	180.3	172.4	142.3
InvestedCapital_A Invested Capital Ann.	1.1%	0.3%	2,884.5	2,827.3	2,780.9	2,792.9	3,054.3	2,838	2,901.3	2,894.4	3,171.6	3,016.3	2,369.6
TangibleBookValue_A Tangible Book Value Ann.	-	-	-993.2	-987.9	-1,193.2	-1,422.4	-1,698	-1,695.5	-1,883.6	-1,990	-2,222.4	-2,696.3	-1,938.6
Borrowings_A Borrowings Ann.	-8.6%	-7.1%	1,045.4	1,044.3	1,139.7	1,367.1	1,506.4	1,514.6	1,766.6	1,798.6	1,993	2,193.7	1,625.3
NetDebt_A Net Debt Ann.	-10.2%	-8.4%	933.1	894.5	1,079.3	1,287.3	1,449.5	1,447.4	1,635.5	1,771.1	1,960.4	2,151.9	1,598.1
ShareIssued_A Share Issued Ann.	0.8%	0.8%	56.2	56	55.5	54.9	54.4	54	53.8	53.7	53.4	53.3	53.1
SHARE_Q Number Of Shares End	-1.6%	-1%	47.5	49.7	49.8	49.8	50.4	50	50.4	51.9	53.1	53	52.8

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Assets Ann.

1Y CHG

2.7%

2Y CAGR

2.6%

3Y CAGR

1.4%

5Y CAGR

0.4%

7Y CAGR

0.2%

10Y CAGR

1.7%

Total Assets Annual growth is higher than historical averages.

Total Current Liabilities Ann.

1Y CHG

13.4%

2Y CAGR

1.6%

3Y CAGR

-9%

5Y CAGR

-0.2%

7Y CAGR

-0.7%

10Y CAGR

1.3%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

2.9%

2Y CAGR

6.8%

3Y CAGR

9.3%

5Y CAGR

6.8%

7Y CAGR

8.1%

10Y CAGR

9.8%

Total ShareHolders Funds Annual growth is lower than historical averages.

Prestige Consumer Healthcare Inc ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Prestige Consumer Healthcare Inc Book Value Per Share is $40 which is growth of 7.3% YoY.
POSITIVE
ROE Prestige Consumer Healthcare Inc ROE is 10% which is growth of 2.1% YoY.

Prestige Consumer Healthcare Inc, Ratios, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
ROA_A RoA Ann. %	-	3.1%	5.52%	6.39%	6.28%	-2.34%	5.79%	4.74%	4.09%	-0.99%	8.85%	2.02%	3.56%
ROE_A ROE Ann. %	-	-4.7%	10.22%	12.30%	13.50%	-5.44%	13.99%	13.02%	12.55%	-3.15%	33.94%	8.86%	14.56%
ROIC_Q ROIC %	-	4.1%	2.2	2	2.2	-7.6	2.1	1.8	1.8	-4	-0.6	1.2	1.2
OPMPCT_A OPM Ann. %	-2.7%	-2.1%	28.42%	30.70%	30.43%	30.84%	30.36%	31.53%	30.23%	30.30%	20.73%	29.19%	32.29%
NBTO_A Inventory Turnover Ratio Ann.	-3.9%	-1.2%	3.2	3.5	3.3	3.6	4	3.4	3.5	3.5	4	3.7	4.1
ASETTO_A Asset Turnover Ann. %	0%	0%	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3
WCTO_A Working Capital Turnover Ann.	-10.6%	-11.4%	3.5	3.3	4.4	4.9	7.3	6.4	4.5	5.6	5.8	5.1	5.7
QuickRatio_A Quick Ratio Ann.	14.5%	11.8%	2.1	2.7	1.9	1.4	1.2	1.2	1.6	1.4	1.4	1.1	1.2
CRATIO_A Current Ratio Ann.	14.5%	10.4%	3.6	4.2	3.2	2.4	2	2.2	2.4	2.4	2.5	2.1	2.3
IC_A Interest Coverage Ratio Ann.	-	15.2%	7.1	7	5.1	-0.4	5.1	3.5	3	0.6	2	2.2	2.8
LTDE_A LT Debt To Equity Ann.	-12.6%	-11.4%	0.6	0.6	0.7	0.9	1	1.1	1.5	1.6	1.7	2.7	2.2

*All financials are in USD Million and price data in USD

Add metric to table

Search...

ROE Ann. %

1Y CHG

-16.9%

2Y CAGR

-13%

5Y CAGR

-4.7%

10Y CAGR

-3.5%

ROE Annual % is falling faster than historical averages.

RoA Ann. %

1Y CHG

-13.6%

2Y CAGR

-6.2%

5Y CAGR

3.1%

10Y CAGR

4.5%

RoA Annual % is falling faster than historical averages.

Current Ratio Ann.

1Y CHG

-14.3%

2Y CAGR

6.1%

3Y CAGR

14.5%

5Y CAGR

10.4%

7Y CAGR

10Y CAGR

4.6%

Current Ratio Annual is falling faster than historical averages.

Prestige Consumer Healthcare Inc cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Prestige Consumer Healthcare Inc Mar-2026 Cash From Operating Activity is $258 Million which is growth of 2.4% YoY.
NEGATIVE
Net Cash Flow Prestige Consumer Healthcare Inc Mar-2026 Net Cash Flow is $-35 Million which is growth of -167.9% YoY.

Prestige Consumer Healthcare Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	3.9%	1.8%	257.6	251.5	248.9	229.7	259.9	235.6	217.1	189.3	210.1	147.8	174.4
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	-	2.9%	190.3	214.6	209.3	-82.3	205.4	164.7	142.3	-35.8	339.6	69.4	99.9
DepreciationAmortizationDepletion_A Depreciation Amortization Depletion Ann.	-1.3%	0.7%	31.3	30.2	30.7	32.6	32.1	30.2	29	31.8	33.4	25.8	23.7
DepreciationAndAmortization_A Depreciation And Amortization Ann.	-1.3%	0.7%	31.3	30.2	30.7	32.6	32.1	30.2	29	31.8	33.4	25.8	23.7
DeferredTax_A Deferred Tax Ann.	-	4.1%	22.7	14.4	23.1	-60.8	10	18.6	13.9	-40.6	-269.1	-5.8	46.2
DeferredIncomeTax_A Deferred Income Tax Ann.	-	4.1%	22.7	14.4	23.1	-60.8	10	18.6	13.9	-40.6	-269.1	-5.8	46.2
EmployeesStockOptions_A ESOPs Ann.	-4.5%	4.9%	10.8	11.2	14	12.4	9	8.5	7.6	7.4	8.9	8.2	10
OtherNonCashItems_A Other Non Cash Items Ann.	21.7%	36.6%	20	10.4	11.4	11.1	10.9	4.2	12.7	6.3	8.7	9.7	-1.5
ChangeInWorkingCapital_A Change In Working Capital Ann.	-	-	-17.6	-41.9	-39.8	-53.9	-11	-5.6	8.8	-8.3	-15.8	-13.3	-21.8
ChangeInReceivables_A Change In Receivables Ann.	-	-	-3.7	-16.3	-6.3	-24.9	-24.7	36.9	-2.9	-3	-5	-18.9	1.8
ChangeInInventory_A Change In Inventory Ann.	-	-	-1.6	-9.3	24.4	-42.2	0.7	3	2.9	-10.5	-2.5	-10.3	-3
ChangePayablesAccruedExpense_A Change Payables Accrued Expense Ann.	-48.9%	-	2.4	-12.4	-41.2	18	18.8	-32.3	18.3	-0.3	-41.5	23.9	-12.7
ChangeInOtherCurrentAssets_A Change In Other Current Assets Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
ChangeInOtherCurrentLiabilities_A Change In Other Current Liabilities Ann.	-	-	-7.8	-7.6	-7.1	-6.7	-6.5	-6.7	-8.8	-	-	-	-
ChangeInOtherWorkingCapital_A Change In Other Working Capital Ann.	-	-	0	-0.9	-1.4	-0.3	-0.7	-3.2	-1.5	-1.4	-0.4	-6.1	-
CFI_A Cash from Investing Act. Ann. ⌄	-	-	-136.8	-17.5	-20.1	-11.6	-256.5	-22.2	-16.6	55.4	-11.6	-694.6	-223
NetPPEPurchaseAndSale_A Net PPE Purchase & Sale Ann.	-	-	-11.2	-8.2	-9.6	-7.8	-9.6	-22.2	-14.6	-10.5	-12.5	-2.9	-3.2
PurchaseOfPPE_A Purchase Of PPE Ann.	-	-	-11.2	-8.2	-9.6	-7.8	-9.6	-22.2	-14.6	-10.5	-12.5	-3	-3.6
NetBusinessPurchaseAndSale_A Net Business Purchase & Sale Ann.	-	-	-123.7	-9.2	-10.6		-247.1			65.9		-693.1	-227
PurchaseOfBusiness_A Purchase Of Business Ann.	-	-	-123.7	-9.2	-10.6		-247.1	-	-			-803.8	-227
PurchaseOfInvestment_A Purchase Of Investment Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
SaleOfInvestment_A Sale Of Investment Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
NetOtherInvestingChanges_A Net Other Investing Changes Ann.	-	-	-1.9	-	-	-3.8	0.2	-	0.8	-	1	1.4	7.2
CFA_A Cash from Financing Act. Ann. ⌄	-	-	-156.1	-182.1	-241	-185.9	-7.6	-279.4	-131.4	-249.3	-209	561.9	54
NetIssuancePaymentsOfDebt_A Net Issuance Payments Of Debt Ann.	-	-	0.5	-139.5	-227.8	-137.8	-5.6	-251.4	-68.5	-200	-209	569.5	58.9
NetLongTermDebtIssuance_A Net Long Term Debt Issuance Ann.	-	-	-2.5	-139.5	-227.8	-137.8	-5.6	-196.4	-48.5	-200	-194	564.5	40
NetShortTermDebtIssuance_A Net ST Debt Issuance Ann.	-	-	3	-				-55	-20		-15	5	18.9
NetCommonStockIssuance_A Net Common Stock Issuance Ann.	-	-	-156.3	-51.5	-25	-50		-11.9	-56.7	-50	-	-	-
CommonStockIssuance_A Common Stock Issuance Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
CommonStockPayments_A Common Stock Payments Ann.	-	-	-156.3	-51.5	-25	-50		-11.9	-56.7	-50	-	-	-
dividend_1Y_actual Dividend 1year	-	-
DividendPerShare_A Dividend Per Share Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
NetOtherFinancingCharges_A Net Other Financing Charges Ann.	-	-	-4.6	-5.8	-6.3	-5.5	-9	-19	-7.6	-2.3	-1.6	-11.7	-12.1
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	3%	14.6%	63.9	97.9	46.5	58.5	27.2	32.3	94.8	27.5	32.6	41.9	27.2
NetIncDecInCashAndCashEquivalents_A Net Increase In Cash Plus Cash Eqv.s Ann.	-	-	-35.3	52	-12.2	32.3	-4.2	-66.1	69.1	-4.6	-10.4	15	5.4
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	53.3%	0.6%	97.9	46.5	58.5	27.2	32.3	94.8	27.5	32.6	41.9	27.2	21.3
IncomeTaxPaidSupplementalData_A Income Tax Paid Supplemental Data Ann.	4.1%	5.9%	45.9	52.1	59.6	40.7	46.6	34.4	30.6	27.5	24.4	-48	-15.4
InterestPaidSupplementalData_A Interest Paid Supplemental Data Ann.	-6.9%	-11.4%	43.8	47.8	63.3	54.2	61.4	80.3	92.2	98.2	98.6	-85.2	-79.1
CapitalExpenditure_A Capex Ann.	-	-	-11.2	-8.2	-9.6	-7.8	-9.6	-22.2	-17.3	-10.5	-12.5	-3	-3.6
IssuanceOfCapitalStock_A Issuance Of Capital Stock Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
IssuanceOfDebt_A Issuance Of Debt Ann.	29.1%	-41.3%	43			20	682	615	500	45	280	1,537	545
RepaymentOfDebt_A Repayment Of Debt Ann.	-	-	-42.5	-139.5	-227.8	-157.8	-687.6	-866.4	-568.5	-245	-489	-967.5	-486.1
RepurchaseOfCapitalStock_A Repurchase Of Capital Stock Ann.	-	-	-156.3	-51.5	-25	-50		-11.9	-56.7	-50	-	-	-
FreeCashFlow_A Free Cash Flow Ann.	3.6%	2.9%	246.5	243.3	239.4	221.9	250.3	213.4	199.8	178.8	197.6	144.8	170.8

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

2.4%

2Y CAGR

1.7%

3Y CAGR

3.9%

5Y CAGR

1.8%

7Y CAGR

4.5%

10Y CAGR

Cash from Operating Activity Annual growth is stable compared to historical averages.

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow

35.84% Fall from 52W High

Prestige Consumer Healthcare Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Prestige Consumer Healthcare Inc - Forecaster

Forecaster Analyst Estimates for Prestige Consumer Healthcare Inc share price target, revenues, EPS, net income and more

Prestige Consumer Healthcare Inc - Earnings Report - Quarterly Results

Prestige Consumer Healthcare Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Quarterly Revenue Prestige Consumer Healthcare Inc Jun-2026 Quarterly Revenue is $266 Million which is growth of 6.5% YoY.

Quarterly Net Profit Prestige Consumer Healthcare Inc Jun-2026 Quarterly Net Profit is $29 Million which is growth of -38.5% YoY.

Prestige Consumer Healthcare Inc - Competitors/Peers

Prestige Consumer Healthcare Inc competitor comparison and performance snapshot within industry

Prestige Consumer Healthcare Inc - Earnings Report - Annual Results

Prestige Consumer Healthcare Inc annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Annual Revenue Prestige Consumer Healthcare Inc Mar-2026 Annual Revenue is $1,089 Million which is growth of -4.3% YoY.

Annual Net Profit Prestige Consumer Healthcare Inc Mar-2026 Annual Net Profit is $190 Million which is growth of -11.3% YoY.

Prestige Consumer Healthcare Inc - Balance Sheet

Prestige Consumer Healthcare Inc balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Total Shareholders Fund Prestige Consumer Healthcare Inc Mar-2026 Total Shareholders Fund is $1,888 Million which is growth of 2.9% YoY.

Total Assets Prestige Consumer Healthcare Inc Mar-2026 Total Assets is $3,494 Million which is growth of 2.7% YoY.

Prestige Consumer Healthcare Inc - Ratios

Prestige Consumer Healthcare Inc ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Book Value Per Share Prestige Consumer Healthcare Inc Book Value Per Share is $40 which is growth of 7.3% YoY.

ROE Prestige Consumer Healthcare Inc ROE is 10% which is growth of 2.1% YoY.

Prestige Consumer Healthcare Inc - Cash Flow

Prestige Consumer Healthcare Inc cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Cash From Operating Activity Prestige Consumer Healthcare Inc Mar-2026 Cash From Operating Activity is $258 Million which is growth of 2.4% YoY.

Net Cash Flow Prestige Consumer Healthcare Inc Mar-2026 Net Cash Flow is $-35 Million which is growth of -167.9% YoY.